PSE Archives - CDR – Chain Drug Review

CHPA hails Georgia for adoption of PSE stop-sale system

May 2, 2016 by Chain Drug Review CHPA, Consumer Healthcare Products Association, methamphetamine, National Precursor Log Exchange, NPLEx, PSE, pseudoephedrine, Scott Melville Supplier News

WASHINGTON — The Consumer Healthcare Products Association (CHPA) has applauded Georgia for becoming the 33rd state to adopt real-time, stop-sale technology for illegal purchases of medication containing pseudoephedrine (PSE). Georgia Gov. Nathan Deal last week signed legislation, approved by the state legislature and sponsored by State Rep. David Clark Clark and State Sen. Renee Unterman (R.),

Consumers: Don’t impede access to PSE medicines

July 14, 2015 by Chain Drug Review and Chain Drug Review AAFA, Asthma and Allergy Foundation of America, medicines containing pseudoephedrine, Meryl Bloomrosen, OTC medicine, prescription-only status, PSE Leading Headlines, Pharmacy, Retail News

WASHINGTON — A survey by the Asthma and Allergy Foundation of America (AAFA) has revealed consumer concerns about access to over-the-counter cold/cough and allergy medicines containing pseudoephedrine (PSE). AAFA said Tuesday that the five-state survey of 2,027 users of OTC medicine for nasal allergies, asthma and/or cold, cough or flu, conducted by Harris Poll, shows